Kingsford Pharmaceuticals

2600 Eastern Beltway, Dallas, Texas 75225

(214) 668-9234 | (214) 688-2394 FAX
Contact: Kristin Hubble, Public Relations Director, Kingsford Pharmaceuticals

September 28, 2016

Cure for West Nile Virus

Kingsford Pharmaceuticals is pleased to announce that its top researchers have developed
a new breakthrough medication, known as X23, that has been produced to fight and cure the
West Nile Virus. The announcement of this breakthrough new medication will take place on
September 28, 2016, only days before the stockholders annual meeting.
If taken with in two weeks of contracting this disease, X23 will completely eliminate all
traces of the disease from the human body. This new cure still needs to be approved by the Food
& Drug Administrative (FDA) before it can be offered to the public. The testing for the FDA will
begin in two weeks.
CEO Roberta Cruz-Suarez states: This medication is a medical breakthrough that will
have profound implications on human health. X23 has the potential to save thousands of lives.
We are confident of securing FDA approval quickly so that we can get X23 into the hands of
doctors and nurses all over the world who will partner with us in the fight against West Nile
Virus.
For more information, please contact Kristin Hubble, Public Relations Director of
Kingsford Pharmaceuticals at the above address.